International Biotechnology Trust’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$410K Hold
310,499
0.14% 61
2023
Q2
$925K Hold
310,499
0.28% 49
2023
Q1
$1.07M Hold
310,499
0.3% 49
2022
Q4
$1.29M Sell
310,499
-196,740
-39% -$745K 0.4% 46
2022
Q3
$2.02M Buy
507,239
+501,007
+8,039% +$3.8M 0.65% 43
2022
Q2
$553K Sell
6,232
-11,768
-65% -$141K 5.77% 4
2022
Q1
$2.38M Hold
18,000
0.54% 40
2021
Q4
$851K Hold
18,000
0.19% 60
2021
Q3
$1.3M Buy
18,000
+12,000
+200% +$868K 0.31% 50
2021
Q2
$503K Sell
6,000
-29,000
-83% -$1.91M 0.13% 61
2021
Q1
$1.69M Buy
+35,000
New +$1.9M 0.45% 36

Other funds holding NBP

International Biotechnology Trust's NBP Position: Q3 2023 in Review

International Biotechnology Trust held its NovaBridge Biosciences American Depositary Shares (NBP) position steady in Q3 2023 at 310,499 shares worth $410K. The position accounts for 0.14% of the portfolio, ranked #61.

International Biotechnology Trust first reported a position in NBP in Q1 2021 and has held it in 11 quarters since. The position peaked at $2.38M in Q1 2022. 47 funds tracked by Wall St. Rank hold NBP as of Q3 2023.

  • International Biotechnology Trust held 310,499 shares of NovaBridge Biosciences American Depositary Shares worth $410K as of Q3 2023.
  • International Biotechnology Trust left its NovaBridge Biosciences American Depositary Shares share count unchanged in Q3 2023.
  • NovaBridge Biosciences American Depositary Shares made up 0.14% of International Biotechnology Trust's portfolio in Q3 2023, its #61 holding.
  • International Biotechnology Trust first reported a position in NovaBridge Biosciences American Depositary Shares in Q1 2021 and has held it in 11 quarters since.
  • International Biotechnology Trust's NovaBridge Biosciences American Depositary Shares position peaked at $2.38M in Q1 2022.
  • 47 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q3 2023.

Based on International Biotechnology Trust's 13F filing for Q3 2023, filed 14 Nov 2023.